For ACTN4, our results indicated that its expression tends to either decrease or remain unchanged in tumor tissues compared to adjacent normal tissues (ANTs) or precancerous tissues across multiple HNSCC cohorts (Supplementary Fig. 1A-I). The gene discussed is ACTN4; the disease is head and neck squamous cell carcinoma.